1-20 of 77
Michael Stadler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Impact of Subclinical FLT3 -ITD Microclones in Patients with Acute Myeloid Leukemia

Paul Olson, Razif Gabdoulline, Rabia Shahswar, Arnold Kloos, Letizia Venturini, Isabell Arnhardt, Henri C. Hupe, Victoria Panagiota, Michael Stadler, Matthias Eder, Gernot Beutel, Elke Dammann, Piroska Poll, Anke Bergmann, Nataliya DiDonato, Florian H. Heidel, Felicitas R. Thol, Michael Heuser
Journal: Blood
Blood (2024) 144 (Supplement 1): 847.
https://doi.org/10.1182/blood-2024-207703
Published: 2024
Journal Articles

Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation

Clara Philine Wienecke, Bennet Heida, Letizia Venturini, Razif Gabdoulline, Katja Krüger, Katrin Teich, Konstantin Büttner, Martin Wichmann, Wolfram Puppe, Blerina Neziri, Marlene Reuter, Elke Dammann, Michael Stadler, Arnold Ganser, Lothar Hambach, Felicitas Thol, Michael Heuser
Journal: Blood
Blood (2024) 144 (3): 296–307.
https://doi.org/10.1182/blood.2023022697
Published: 2024
Includes: Supplemental data
Journal Articles

Myelodysplasia-Related Gene Mutations for NGS-Based MRD Assessment in Acute Myeloid Leukemia

Maximilian Bader, Arba Mahmuti, Jannika Leßmann, Henri C Hupe, Razif Gabdoulline, Martin Wichmann, Letizia Venturini, Michael Stadler, Wolfram Puppe, Walter Fiedler, Jürgen Krauter, Arne Trummer, Bernd Hertenstein, Matthias Eder, Arnold Ganser, Felicitas Thol, Michael Heuser, Rabea Mecklenbrauck
Journal: Blood
Blood (2023) 142 (Supplement 1): 2944.
https://doi.org/10.1182/blood-2023-181637
Published: 2023
Journal Articles

Detection of Isolated Extramedullary AML Using Next-Generation Sequencing of Cell-Free DNA

Henri C. Hupe, Clara P. Wienecke, Stephan Bartels, Elisa Schipper, Jannika Leßmann, Alina Lasch, Maximilian Bader, Razif Gabdoulline, Martin Wichmann, Wolfram Puppe, Michael Stadler, Matthias Eder, Arnold Ganser, Felicitas Thol, Michael Heuser
Journal: Blood
Blood (2023) 142 (Supplement 1): 4330.
https://doi.org/10.1182/blood-2023-181522
Published: 2023
Journal Articles

Fla-IDA Chemotherapy with or without Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Rabia Shahswar, Gernot Beutel, Razif Gabdoulline, Adrian Schwarzer, Arnold Kloos, Christian Koenecke, Michael Stadler, Gudrun Göhring, Brigitte Schlegelberger, Zhixiong Li, Louisa-Kristin Dallmann, Clara Wienecke, Piroska Klement, Catherin Albert, Martin Wichmann, Yasmine Alwie, Axel Benner, Maral Saadati, Arnold Ganser, Felicitas R. Thol, Michael Heuser
Journal: Blood
Blood (2022) 140 (Supplement 1): 3315–3316.
https://doi.org/10.1182/blood-2022-163430
Published: 2022
Journal Articles

Clonal Relapse Dynamics in Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation

Clara Wienecke, Bennet Heida, Katrin Teich, Konstantin Büttner, Alessandro Liebich, Razif Gabdoulline, Letizia Venturini, Martin Wichmann, Wolfram Puppe, Michael Stadler, Arnold Ganser, Felicitas Thol, Michael Heuser
Journal: Blood
Blood (2021) 138 (Supplement 1): 611.
https://doi.org/10.1182/blood-2021-149081
Published: 2021
Journal Articles

Hematologic Recovery from Venetoclax-Containing Regimens in Relapsed/Refractory Acute Myeloid Leukemia Patients Depending on Prior Allogeneic Hematopoietic Cell Transplantation

Rabia Shahswar, MD, Gernot Beutel, MD, Piroska Klement, Alina Rehberg, Razif Gabdoulline, Christian Koenecke, MD, Dominik Markel, MD, Hendrik Eggers, MD, Matthias Eder, MD, Michael Stadler, MD PhD, Lothar Hambach, MD, Steve Ehrlich, MD, Gudrun Gohring, MD, Brigitte Schlegelberger, MD, Arne Trummer, MD, Juergen Krauter, MD, Arnold Ganser, MD, Felicitas Thol, MD, Michael Heuser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1359.
https://doi.org/10.1182/blood-2019-125377
Published: 2019
Journal Articles

Post Transplantation Measurable Residual Disease (MRD) Monitoring Using Next-Generation Sequencing Is Highly Predictive for Relapseafter Allogeneic Stem Cell Transplantation

Felicitas Thol, MD, Bennet Heida, Konstatin Buettner, Clara Wienecke, Katrin Teich, Carolin Funke, Brandes Maximilian, Piroska Klement, Alessandro Liebich, Johannes Schiller, Martin Wichmann, Blerina Neziri, Anuhar Chaturvedi, PhD, Arnold Kloos, PhD, Verena I. Gaidzik, MD, Peter Paschka, MD, Lars Bullinger, Walter Fiedler, MD, Albert Heim, MD, Jürgen Krauter, MD, Konstanze Döhner, Hartmut Döhner, MD, Arnold Ganser, MD, Michael Stadler, MD PhD, Lothar Hambach, MD, Razif Gabdoulline, Michael Heuser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 184.
https://doi.org/10.1182/blood-2019-125532
Published: 2019
Journal Articles

T Regulatory Cell Receptor Repertoire Focusing and Clonal Expansion Indicates Control of Acute GvHD after Donor Lymphocyte Infusion

Christian R Schultze-Florey, MD, Leonie Kuhlmann, cand. MD, Solaiman Raha, PhD, Ivan Odak, MSc, Saleh Tavil, cand. MD, Melanie Drenker, Elke Dammann, Lothar Hambach, Steve Ehrlich, MD, Michael Stadler, MD PhD, Michael Heuser, MD, Felicitas Thol, MD, Reinhold Foerster, DVM, PhD, Arnold Ganser, MD, Immo Prinz, PhD, Christian Koenecke
Journal: Blood
Blood (2018) 132 (Supplement 1): 822.
https://doi.org/10.1182/blood-2018-99-116083
Published: 2018
Journal Articles

Prospective Multicenter Phase 3 Study Comparing 5-Azacytidine (5-Aza) Induction Followed By Allogeneic Stem Cell Transplantation Versus Continuous 5-Aza According to Donor Availability in Elderly MDS Patients (55-70 years) (VidazaAllo Study)

Nicolaus Kroeger, Katja Sockel, MD, Christine Wolschke, MD, Wolfgang Bethge, MD, Richard F. Schlenk, MD, Dominik Wolf‎, MD, Michael Stadler, MD PhD, Guido Kobbe, Gerald Wulf, MD, Gesine Bug, Kerstin Schäfer-Eckart, MD, Christoph Scheid, MD, Florian Nolte, MD, Jan Krönke, MD, Matthias Stelljes, MD, Dietrich W. Beelen, Marion Heinzelmann, Detlef Haase, MD PhD, Hannes Buchner, Dr., Gabriele Bleckert, Dr., Uwe Platzbecker
Journal: Blood
Blood (2018) 132 (Supplement 1): 208.
https://doi.org/10.1182/blood-2018-99-115932
Published: 2018
Journal Articles

Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML

Clinical Trials & Observations
Felicitas Thol, Razif Gabdoulline, Alessandro Liebich, Piroska Klement, Johannes Schiller, Christian Kandziora, Lothar Hambach, Michael Stadler, Christian Koenecke, Madita Flintrop, Mira Pankratz, Martin Wichmann, Blerina Neziri, Konstantin Büttner, Bennet Heida, Sabrina Klesse, Anuhar Chaturvedi, Arnold Kloos, Gudrun Göhring, Brigitte Schlegelberger, Verena I. Gaidzik, Lars Bullinger, Walter Fiedler, Albert Heim, Iyas Hamwi, Matthias Eder, Jürgen Krauter, Richard F. Schlenk, Peter Paschka, Konstanze Döhner, Hartmut Döhner, Arnold Ganser, Michael Heuser
Journal: Blood
Blood (2018) 132 (16): 1703–1713.
https://doi.org/10.1182/blood-2018-02-829911
Published: 2018
Includes: Supplemental data
Journal Articles

Adoptive Cellular Therapy with Donor Lymphocyte Infusion Versus a Second Allogeneic Hematopoietic Cell Transplant for Post-Allograft Relapsed Acute Myeloid Leukemia: An Intent-to-Treat Analysis on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Mohamed A Kharfan-Dabaja, MD, Myriam Labopin, MD, Emmanuelle Polge, Taiga Nishihori, MD, Ali Bazarbachi, MD PhD, Jürgen Finke, MD, Michael Stadler, MD PhD, Gerhard Ehninger, Bruno Lioure, MD, Nicolaas Schaap, Boris V Afanasyev, MD PhD Professor, Moshe Yeshurun, Cecilia Isaksson, Johan Maertens, Yves Chalandon, MD PhD, Christoph Schmid, Arnon Nagler, MD, Mohamad Mohty, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 273.
https://doi.org/10.1182/blood.V130.Suppl_1.273.273
Published: 2017
Journal Articles

The Multicentre, Double-Blinded, Placebo-Controlled Clinical-Trial (Pre-GvHD) for Prediction and Pre-Emptive Treatment of Acute GvHD

Eva M Weissinger, MD, Metzger Jochen, PhD, Michael Schleuning, MD, Christoph Schmid, Diethelm Messinger, Gernot Beutel, MD, Eva-Maria Wagner, MD, Johannes Schetelig, MD, Herrad Baurmann, MD, Andreas Rank, MD, Friedrich Stolzl, MD, Kerstin Schäfer-Eckhard, MD, Karin Westphal, Wolfgang Bethge, MD, Donald w. Bunjes, MD, Daniela Heidenreich, MD, Stefan Klein, MD, Daniel Wolff, MD, Ernst Holler, MD, Hans H Kreipe, MD PhD, Danny Jonigk, Irina Türüchanow, Clara Rothmann, Julia Raad, Annika Durban, Iyas Hamwi, MD, Steve Ehrlich, MD, Patrick Schweier, Jurgen Krauter, MD, Michael Stadler, MD PhD, Arnold Ganser, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 512.
https://doi.org/10.1182/blood.V130.Suppl_1.512.512
Published: 2017
Journal Articles

Long-Term Efficacy of Reduced-Intensity Conditioning Compared to Standard Myeloablative Conditioning before Allogeneic Hemopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission: 10-Year Follow-up of a Prospective, Open-Label Randomized Phase III Trial

Frederick Fasslrinner, MD, Johannes Schetelig, MD, Andreas Burchert, MD, Michael Kramer, M.Sc., Rudolf Trenschel, MD, Ute Hegenbart, Michael Stadler, MD PhD, Kerstin Schäfer-Eckart, MD, Michael Bätzel, Hans Eich, MD, Rita Engenhart-Cabillic, MD, Mechthild Krause, MD, Peter Dreger, MD, Andreas Neubauer, MD, Gerhard Ehninger, Dietrich W Beelen, MD PhD, Wolfgang E. Berdel, Timo Siepmann, MD, Matthias Stelljes, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4586.
https://doi.org/10.1182/blood.V130.Suppl_1.4586.4586
Published: 2017
Journal Articles

Next-Generation Sequencing-Based Measurable Residual Disease (MRD) Monitoring Is Highly Predictive for Outcome after Allogeneic Stem Cell Transplantation

Felicitas Thol, MD, Alessandro Liebich, Razif Gabdoulline, PhD, Piroska Klement, Johannes Schiller, Christian Kandziora, Madita Flintrop, Mira Pankratz, Martin Wichmann, Blerina Neziri, Sabrina Klesse, Anuhar Chaturvedi, PhD, Arnold Kloos, PhD, Verena I. Gaidzik, MD, Peter Paschka, MD, Lars Bullinger, MD, Walter Fiedler, MD, Albert Heim, MD, Lothar Hambach, MD, Michael Stadler, MD PhD, Iyas Hamwi, MD, Matthias Eder, Jürgen Krauter, MD, Richard F. Schlenk, MD, Konstanze Dohner, MD, Hartmut Döhner, MD, Arnold Ganser, MD, Michael Heuser, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4513.
https://doi.org/10.1182/blood.V130.Suppl_1.4513.4513
Published: 2017
Journal Articles

Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial

Clinical Trials & Observations
Isabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, Sebastian Böttcher, Matthias Zeis, Michael Stadler, Jörg Bittenbring, Lutz Uharek, Christof Scheid, Ute Hegenbart, Anthony Ho, Michael Hallek, Michael Kneba, Norbert Schmitz, Hartmut Döhner, Peter Dreger
Journal: Blood
Blood (2017) 130 (12): 1477–1480.
https://doi.org/10.1182/blood-2017-04-775841
Published: 2017
Includes: Supplemental data
Journal Articles

Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 10-Year Follow-up of the Gcllsg CLL3X Trial

Isabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, Sebastian Böttcher, Matthias Ritgen, Donald Bunjes, Matthias Zeis, Michael Stadler, MD, Joerg Thomas Bittenbring, MD, Ute Hegenbart, Michael Hallek, Michael Kneba, Norbert Schmitz, MD, PhD, Hartmut Döhner, MD, Peter Dreger, MD
Journal: Blood
Blood (2016) 128 (22): 682.
https://doi.org/10.1182/blood.V128.22.682.682
Published: 2016
Journal Articles

Impact of Immune Reconstitution (IR) and Graft-Versus-Host Disease (GvHD) on Clinical Outcomes after Treatment with Donor T Cells Transduced to Express the Herpes Simplex Virus Thymidine-Kinase Suicide Gene (TK cells) in Acute Leukemia Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Fabio Ciceri, MD, Chiara Bonini, MD, Arnon Nagler, MD, Evangelia Yannaki, MD, Maria Teresa Lupo Stanghellini, MD, Attilio Bondanza, MD PhD, Raffaella Greco, MD, Eduardo Olovarria, MD, Eva M. Mischak-Weissinger, MD, Michael Stadler, MD, Donald w. Bunjes, Dietger Niederwieser, MD, Lutz Uharek, MD, Wolfgang Betghe, MD, John F DiPersio, MD PhD, Michele L. Donato, MD, Andrew L. Pecora, MD, Scialini Colombi, Antonio Lambiase, MD, Claudio Bordignon, MD
Journal: Blood
Blood (2016) 128 (22): 4599.
https://doi.org/10.1182/blood.V128.22.4599.4599
Published: 2016
Journal Articles

TCR Diversity Is a Predictive Marker for Donor Lymphocyte Infusion Response

Christian Schultze-Florey, MD, Solaiman Raha, Sarina Ravens, PhD, Leonie Kuhlmann, Melanie Drenker, Linda Oberdörfer, Anke Breithaupt, Elke Dammann, Lothar Hambach, MD, Michael Stadler, MD, Michael Heuser, MD, Felicitas Thol, MD, Reinhold Foerster, Prof., Arnold Ganser, MD, Immo Prinz, Prof., Christian Koenecke, MD
Journal: Blood
Blood (2016) 128 (22): 4605.
https://doi.org/10.1182/blood.V128.22.4605.4605
Published: 2016
Journal Articles

The Risk of Sinusoidal Obstruction Syndrome (SOS) in Allogeneic Hematopoietic Stem Cell Transplantation after Prior Gemtuzumab Ozogamicin Treatment: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Giorgia Battipaglia, Myriam Labopin, MD, Anna Candoni, MD, Renato Fanin, Jean El Cheikh, Didier Blaise, Mauricette Michallet, MD PhD, Annalisa Ruggeri, MD PhD, Natalie Contentin, Josep Ribera, MD PhD, Michael Stadler, MD, Jorge Sierra, MD PhD, Peter A. Von Dem Borne, Adrian Bloor, FRCPath, Gerard Socie, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc
Journal: Blood
Blood (2015) 126 (23): 3110.
https://doi.org/10.1182/blood.V126.23.3110.3110
Published: 2015